Researcher
Beppe Floris
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From29 Oct 2007 → 2 Feb 2011 - Translational Cell & Tissue Research (Division)
Member
From12 May 2004 → Today
Projects
11 - 20 of 20
- Integration of complementary, high throughput single-cell omics with spatial resolution.From1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- HISTOPATHOLOGICAL HETEROGENEITY OF PRIMARY AND METASTATIC BREAST CANCERFrom1 Oct 2019 → 15 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Linking patient adiposity to tumour microenvironment and therapy response in breast cancer: towards tailored treatment strategies in obesityFrom27 Sep 2019 → 30 Sep 2023Funding: FWO Strategic Basic Research Grant, Foundations, funds and other with scientific goal
- Dissection of molecular determinants of metastasis and detailed characterization of the age-related immunological profile in (older) patients with hormone-sensitive breast cancerFrom1 Sep 2019 → 11 Dec 2023Funding: Foundations, funds and other with scientific goal
- Postpartum breast cancer diagnosed during involution: a distinct entity with unique clinicopathological, molecular and immunological features?From1 Jan 2019 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic settingFrom1 May 2017 → 14 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancerFrom1 Oct 2016 → 15 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Key biological processes involved in breast cancer invasion and metastases leading to residual disease after local therapy of breast tumors.From1 Jul 2014 → 30 Jun 2018Funding: Private funding of national origin - undefined
- Impact of ageing and immunosenescence on breast tumor stroma and relation with plasma ageing biomarkers and clinical outcome.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 169
- Reporting on invasive lobular breast cancer in clinical trials: a systematic review.(2024)
Authors: Karen Van Baelen, Josephine Van Cauwenberge, Beppe Floris, Patrick Neven, Hans Wildiers, Christine Desmedt
Pages: 23 - Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy.(2023)
Authors: Maxim De Schepper, Ha Linh Nguyen, François Richard, Sophia Leduc, Hans Wildiers, Ines Nevelsteen, Patrick Neven, Beppe Floris, Christine Desmedt
Pages: 186 - 199 - Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases(2023)
Authors: Sophia Leduc, Maxim De Schepper, François Richard, Anirudh Pabba, Kristien Borremans, Gitte Zels, Karen Van Baelen, Ha Linh Nguyen, Tatjana Geukens, Baki Topal, et al.
- High-grade HER2-positive mucoepidermoid carcinoma of the breast: a case report and review of the literature(2023)
Authors: Esther Hauben, Caroline Weltens, Ines Nevelsteen, Beppe Floris
- Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer(2023)
Authors: Yentl Lambrechts, Abhishek Garg, Beppe Floris, Patrick Neven, Ines Nevelsteen, François Richard, Annouschka Laenen, Christine Desmedt, Hans Wildiers, Sigrid Hatse
Pages: 270 - 279 - Innovative translational research approaches for unmet clinical needs in breast cancer(2023)
Authors: Tatjana Geukens, Christine Desmedt, Hans Wildiers, Beppe Floris
- Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features(2023)
Authors: Beppe Floris, Kristel Van Calsteren, Patrick Neven, Sileny Han, Daniela Annibali, Diether Lambrechts, Liesbeth Lenaerts, Frédéric Amant
Pages: 3729 - 3743 - HISTOPATHOLOGICAL HETEROGENEITY OF PRIMARY AND METASTATIC BREAST CANCER(2023)
Authors: Maxim De Schepper, Christine Desmedt, Beppe Floris
- Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer(2023)
Authors: Karen Van Baelen, Ha Linh Nguyen, François Richard, Maxim De Schepper, Tatjana Geukens, Sileny Han, Thaïs Baert, Hans Wildiers, Ann Smeets, Ines Nevelsteen, et al.
- Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors(2023)
Authors: Yentl Lambrechts, Sigrid Hatse, François Richard, Bram Boeckx, Beppe Floris, Christine Desmedt, Patrick Neven, Diether Lambrechts, Hans Wildiers